Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC

The L-type calcium channel blocker fendiline has been shown to interfere with Ras-dependent signaling in K-Ras mutant cancer cells. Earlier studies from our lab had shown that treatment of pancreatic cancer cells with fendiline causes significant cytotoxicity and interferes with proliferation, survi...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhothali, Marwa, Mathew, Mevin, Iyer, Geeta, Lawrence, Harshani R., Yang, Shengyu, Chellappan, Srikumar, Padmanabhan, Jaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567171/
https://www.ncbi.nlm.nih.gov/pubmed/31100813
http://dx.doi.org/10.3390/ijms20102423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567171/
https://www.ncbi.nlm.nih.gov/pubmed/31100813
http://dx.doi.org/10.3390/ijms20102423

Ejemplares similares